Company intelligence / Profile preview

GeneFab

Alameda, California, United Statesgenefab.com ↗

Ownership: Private
Employees: ~90
Development stage: Phase 1

Overview

GeneFab does not have proprietary clinical results or an internal drug pipeline. It provides advanced cGMP manufacturing services—including process development and regulatory support—for innovators developing genetic medicines. It currently supports the clinical manufacturing of Senti Bio’s off-the-shelf CAR-NK pipeline through service contracts. No active trials are listed under its name on ClinicalTrials.gov.

Therapeutic areas: OncologyImmunology
Modalities: Cell therapyGene therapyViral vector-based therapies
Industry: Contract Manufacturing Organization

Partnerships

RegCellSenti Bio

Beyond the preview

Go deeper on GeneFab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GeneFab.

Explore the full profile